|
Volumn 18, Issue 4 Suppl A, 2012, Pages
|
Looking at CER from the pharmaceutical industry perspective.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACCESS TO INFORMATION;
ARTICLE;
COMPARATIVE EFFECTIVENESS;
DECISION MAKING;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
ECONOMICS;
HEALTH CARE POLICY;
HUMAN;
INTERPERSONAL COMMUNICATION;
LEGAL ASPECT;
MANAGEMENT;
METHODOLOGY;
ORGANIZATION AND MANAGEMENT;
UNITED STATES;
ACCESS TO INFORMATION;
COMMUNICATION;
COMPARATIVE EFFECTIVENESS RESEARCH;
DECISION MAKING;
DRUG DISCOVERY;
DRUG INDUSTRY;
HEALTH CARE REFORM;
HUMANS;
POLICY MAKING;
UNITED STATES;
|
EID: 84866267011
PISSN: None
EISSN: 1944706X
Source Type: Journal
DOI: 10.18553/jmcp.2012.18.s4-a.s09 Document Type: Article |
Times cited : (4)
|
References (0)
|